The S&P 500 fell 1.1% on Wednesday, March 26, 2025, as tech stocks faltered and the White House prepared to announce tariffs ...
12h
Dealbreaker on MSNGoldman Sachs Backs Value-Based Healthcare AI CopilotIt provides an AI copilot that gathers and analyzes patient data from the EHR and other disparate sources to facilit ...
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...
Morgan Stanley boosted Plains All American Pipeline, L.P. PAA price target from $19 to $23. Morgan Stanley analyst Robert Kad ...
Goldman Sachs acquired shares worth Rs 87 crore from Samvardhana Motherson International. Simultaneously, Hong Kong-based ...
Navina, a market leader in AI-powered clinical intelligence, today announced the successful completion of a $55 million Series C funding round, bringing the total funding to $100 million. The round is ...
Clinician AI assistant company Navina has raised a $55 million series C funding round, the company announced Tuesday. | ...
The healthcare startup raised fresh Series C funding for its AI that helps clinics aggregate patient data to deliver better ...
US stocks surged with strong gains in tech, banking, and airline sectors. Investors welcomed reports of scaled-back tariffs, fueling a bullish market mood.
Moderna (NASDAQ:MRNA – Get Free Report) had its price objective lowered by analysts at JPMorgan Chase & Co. from $40.00 to ...
Danaher (NYSE:DHR) traded higher in the premarket on Friday after Goldman Sachs upgraded the life sciences company to Buy ...
Goldman Sachs analyst Chris Shibutani maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $136.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results